Skip to main content
Top
Published in: Fluids and Barriers of the CNS 1/2018

Open Access 01-12-2018 | Short paper

Nimodipine treatment does not benefit juvenile ferrets with kaolin-induced hydrocephalus

Authors: Domenico L. Di Curzio, Xiaoyan Mao, Aidan Baker, Marc R. Del Bigio

Published in: Fluids and Barriers of the CNS | Issue 1/2018

Login to get access

Abstract

Prior research on 3-week hydrocephalic rats showed that behavioral deficits and white matter damage could be reduced by treatment with Ca2+ channel blocker nimodipine. We hypothesized that treatment with nimodipine would be also beneficial to young ferrets with kaolin-induced hydrocephalus. Hydrocephalus was induced at 14 days of age and animals were treated either with vehicle, low dose nimodipine (3.2 mg/kg/day), or high dose nimodipine (16 mg/kg/day) for 2 weeks from 38 to 52 days age. Hydrocephalic ferrets developed progressive ventriculomegaly, behavioral changes, and in some cases cortical blindness. These changes were not ameliorated by nimodipine. Histological examination showed damage in periventricular white matter, corpus callosum thinning, axonal damage, reactive astroglial changes, and suppressed cell proliferation compared to non-hydrocephalic controls. Treatment with nimodipine was not beneficial for any of the pathological changes mentioned above; only low dose nimodipine treatment was associated with normalized content of glial fibrillary acidic protein, despite larger ventricles. We conclude that young hydrocephalic ferrets experience behavioral impairments and structural brain damage that are not consistently improved by intermittent nimodipine treatment. Continuous delivery should be considered in further preclinical studies.
Literature
1.
go back to reference Del Bigio MR. Neuropathology and structural changes in hydrocephalus. Dev Disabil Res Rev. 2010;16:16–22.CrossRefPubMed Del Bigio MR. Neuropathology and structural changes in hydrocephalus. Dev Disabil Res Rev. 2010;16:16–22.CrossRefPubMed
3.
go back to reference Scriabine A, van den Kerckhoff W. Pharmacology of nimodipine. A review. Ann N Y Acad Sci. 1988;522:698–706.CrossRefPubMed Scriabine A, van den Kerckhoff W. Pharmacology of nimodipine. A review. Ann N Y Acad Sci. 1988;522:698–706.CrossRefPubMed
4.
go back to reference Scriabine A, Schuurman T, Traber J. Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J. 1989;3:1799–806.CrossRefPubMed Scriabine A, Schuurman T, Traber J. Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J. 1989;3:1799–806.CrossRefPubMed
5.
go back to reference Yuan XQ, Smith TL, Prough DS, De Witt DS, Dusseau JW, Lynch CD, Fulton JM, Hutchins PM. Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats. Am J Physiol. 1990;258:H1395–401.PubMed Yuan XQ, Smith TL, Prough DS, De Witt DS, Dusseau JW, Lynch CD, Fulton JM, Hutchins PM. Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats. Am J Physiol. 1990;258:H1395–401.PubMed
6.
go back to reference Schmidt JF, Albeck M, Gjerris F. The effect of nimodipine on ICP and CBF in patients with normal-pressure hydrocephalus. Acta Neurochir (Wien). 1990;102:11–3.CrossRef Schmidt JF, Albeck M, Gjerris F. The effect of nimodipine on ICP and CBF in patients with normal-pressure hydrocephalus. Acta Neurochir (Wien). 1990;102:11–3.CrossRef
7.
go back to reference Del Bigio MR, Massicotte EM. Protective effect of nimodipine on behavior and white matter of rats with hydrocephalus. J Neurosurg. 2001;94:788–94.CrossRefPubMed Del Bigio MR, Massicotte EM. Protective effect of nimodipine on behavior and white matter of rats with hydrocephalus. J Neurosurg. 2001;94:788–94.CrossRefPubMed
8.
go back to reference Di Curzio DL, Buist RJ, Del Bigio MR. Reduced subventricular zone proliferation and white matter damage in juvenile ferrets with kaolin-induced hydrocephalus. Exp Neurol. 2013;248:112–28.CrossRefPubMed Di Curzio DL, Buist RJ, Del Bigio MR. Reduced subventricular zone proliferation and white matter damage in juvenile ferrets with kaolin-induced hydrocephalus. Exp Neurol. 2013;248:112–28.CrossRefPubMed
9.
go back to reference Di Curzio DL, Turner-Brannen E, Mao X, Del Bigio MR. Magnesium sulfate treatment for juvenile ferrets following induction of hydrocephalus with kaolin. Fluids Barriers CNS. 2016;13:7.CrossRefPubMedPubMedCentral Di Curzio DL, Turner-Brannen E, Mao X, Del Bigio MR. Magnesium sulfate treatment for juvenile ferrets following induction of hydrocephalus with kaolin. Fluids Barriers CNS. 2016;13:7.CrossRefPubMedPubMedCentral
10.
go back to reference Workman AD, Charvet CJ, Clancy B, Darlington RB, Finlay BL. Modeling transformations of neurodevelopmental sequences across mammalian species. J Neurosci. 2013;33:7368–83.CrossRefPubMedPubMedCentral Workman AD, Charvet CJ, Clancy B, Darlington RB, Finlay BL. Modeling transformations of neurodevelopmental sequences across mammalian species. J Neurosci. 2013;33:7368–83.CrossRefPubMedPubMedCentral
11.
go back to reference Jacobson S. Sequence of myelinization in the brain of the albino rat. A. Cerebral cortex, thalamus and related structures. J Comp Neurol. 1963;121:5–29.CrossRefPubMed Jacobson S. Sequence of myelinization in the brain of the albino rat. A. Cerebral cortex, thalamus and related structures. J Comp Neurol. 1963;121:5–29.CrossRefPubMed
12.
go back to reference Turner PV, Brabb T, Pekow C, Vasbinder MA. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2011;50:600–13.PubMedPubMedCentral Turner PV, Brabb T, Pekow C, Vasbinder MA. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2011;50:600–13.PubMedPubMedCentral
13.
go back to reference Koskimaki J, Tarkia M, Ahtola-Satila T, Saloranta L, Laakso A, Frantzen J. Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation. Eur J Drug Metab Pharmacokinet. 2016;41:295–300.CrossRefPubMed Koskimaki J, Tarkia M, Ahtola-Satila T, Saloranta L, Laakso A, Frantzen J. Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation. Eur J Drug Metab Pharmacokinet. 2016;41:295–300.CrossRefPubMed
14.
go back to reference Etminan N, Macdonald RL, Davis C, Burton K, Steiger HJ, Hanggi D. Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl. 2015;120:281–6.PubMed Etminan N, Macdonald RL, Davis C, Burton K, Steiger HJ, Hanggi D. Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl. 2015;120:281–6.PubMed
15.
go back to reference Kong H, Yu F, Liu Y, Yang Y, Li M, Cheng X, Hu X, Tang X, Li Z, Mei X. Development and evaluation of high bioavailable sustained-release nimodipine tablets prepared with monolithic osmotic pump technology. Curr Drug Deliv. 2018;15:44–51.CrossRefPubMed Kong H, Yu F, Liu Y, Yang Y, Li M, Cheng X, Hu X, Tang X, Li Z, Mei X. Development and evaluation of high bioavailable sustained-release nimodipine tablets prepared with monolithic osmotic pump technology. Curr Drug Deliv. 2018;15:44–51.CrossRefPubMed
16.
go back to reference Jacob SW, Wood DC. Dimethyl sulfoxide (DMSO). Toxicology, pharmacology, and clinical experience. Am J Surg. 1967;114:414–26.CrossRefPubMed Jacob SW, Wood DC. Dimethyl sulfoxide (DMSO). Toxicology, pharmacology, and clinical experience. Am J Surg. 1967;114:414–26.CrossRefPubMed
17.
go back to reference Noel PR, Barnett KC, Davies RE, Jolly DW, Leahy JS, Mawdesley-Thomas LE, Shillam KW, Squires PF, Street AE, Tucker WC, Worden AN. The toxicity of dimethyl sulphoxide (DMSO) for the dog, pig, rat and rabbit. Toxicology. 1975;3:143–69.CrossRefPubMed Noel PR, Barnett KC, Davies RE, Jolly DW, Leahy JS, Mawdesley-Thomas LE, Shillam KW, Squires PF, Street AE, Tucker WC, Worden AN. The toxicity of dimethyl sulphoxide (DMSO) for the dog, pig, rat and rabbit. Toxicology. 1975;3:143–69.CrossRefPubMed
18.
go back to reference Kim NN, Parker RM, Weinbauer GF, Remick AK, Steinbach T. Points to consider in designing and conducting juvenile toxicology studies. Int J Toxicol. 2017;36:325–39.CrossRefPubMed Kim NN, Parker RM, Weinbauer GF, Remick AK, Steinbach T. Points to consider in designing and conducting juvenile toxicology studies. Int J Toxicol. 2017;36:325–39.CrossRefPubMed
Metadata
Title
Nimodipine treatment does not benefit juvenile ferrets with kaolin-induced hydrocephalus
Authors
Domenico L. Di Curzio
Xiaoyan Mao
Aidan Baker
Marc R. Del Bigio
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Fluids and Barriers of the CNS / Issue 1/2018
Electronic ISSN: 2045-8118
DOI
https://doi.org/10.1186/s12987-018-0099-0

Other articles of this Issue 1/2018

Fluids and Barriers of the CNS 1/2018 Go to the issue